When.com Web Search

  1. Ads

    related to: 23 and me interpretation websites

Search results

  1. Results From The WOW.Com Content Network
  2. The rise and fall of 23andMe - AOL

    www.aol.com/rise-fall-23andme-145109007.html

    Despite the privacy concerns, 23andMe began to gain recognition for the work of its researchers. Time Magazine named 23andMe's Personal Genome Service its Invention of the Year in 2008.

  3. 23andMe - Wikipedia

    en.wikipedia.org/wiki/23andMe

    23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. [1] It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, [2] to generate reports relating to the customer's ancestry and genetic ...

  4. Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring ...

  5. Impute.me - Wikipedia

    en.wikipedia.org/wiki/Impute.me

    Impute.me was an open-source non-profit web application that allowed members of the public to use their data from direct-to-consumer (DTC) genetic tests (including tests from 23andMe and Ancestry.com) to calculate polygenic risk scores (PRS) for complex diseases and cognitive and personality traits.

  6. 23andMe data leak - Wikipedia

    en.wikipedia.org/wiki/23andMe_data_leak

    In October 2023, Wired reported that a sample of data points from 23andMe accounts were exposed on BreachForums, a black-hat hacking crime forum. [1]23andMe confirmed to TechCrunch that because of an opt-in feature that allows DNA-related relatives to contact each other, the true number of people exposed was 6.9 million, nearly half of 23andMe’s 14 million reported customers.

  7. 23andMe shares rise 21% on first day of trading on Nasdaq - AOL

    www.aol.com/news/23-and-me-shares-begin-trading...

    Shares of 23andMe rose in their trading debut on the Nasdaq as the consumer genetic testing company became one of the latest companies to go public via SPAC deal.